Physiological coreceptor use by dual-tropic HIV-1: one plus one equals one.
作者信息
Rollins B J
机构信息
Department of Adult Oncology, Dana-Farber Cancer Institute, Boston Massachusetts 02115, USA.
出版信息
J Clin Invest. 1999 Sep;104(5):531-2. doi: 10.1172/JCI8160.
Abstract
摘要
相似文献
1
Physiological coreceptor use by dual-tropic HIV-1: one plus one equals one.
J Clin Invest. 1999 Sep;104(5):531-2. doi: 10.1172/JCI8160.
2
Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
J Clin Invest. 1999 Sep;104(5):R7-R11. doi: 10.1172/JCI7403.
3
Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Exp Mol Pathol. 2000 Jun;68(3):133-8. doi: 10.1006/exmp.1999.2300.
4
HIV and SIV gp120 binding does not predict coreceptor function.
Virology. 1999 Jul 5;259(2):267-73. doi: 10.1006/viro.1999.9779.
5
T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.
J Immunol. 1999 May 15;162(10):6263-7.
6
The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
Virology. 2002 Jan 5;292(1):98-106. doi: 10.1006/viro.2001.1266.
7
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Nature. 1997 Oct 30;389(6654):981-5. doi: 10.1038/40173.
8
Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism.
Retrovirology. 2013 Nov 11;10:130. doi: 10.1186/1742-4690-10-130.
9
Identification of a major co-receptor for primary isolates of HIV-1.
Nature. 1996 Jun 20;381(6584):661-6. doi: 10.1038/381661a0.
10
Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
J Clin Virol. 2008 Sep;43(1):25-31. doi: 10.1016/j.jcv.2008.03.026. Epub 2008 May 6.
本文引用的文献
1
Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
J Clin Invest. 1999 Sep;104(5):R7-R11. doi: 10.1172/JCI7403.
2
Constitutive cell surface association between CD4 and CCR5.
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7496-501. doi: 10.1073/pnas.96.13.7496.
3
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
Annu Rev Immunol. 1999;17:657-700. doi: 10.1146/annurev.immunol.17.1.657.
4
Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?
J Virol. 1999 Apr;73(4):3443-8. doi: 10.1128/JVI.73.4.3443-3448.1999.
5
The antigenic structure of the HIV gp120 envelope glycoprotein.
Nature. 1998 Jun 18;393(6686):705-11. doi: 10.1038/31514.
6
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
Nature. 1998 Jun 18;393(6686):648-59. doi: 10.1038/31405.
7
The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
Science. 1998 Jun 19;280(5371):1884-8. doi: 10.1126/science.280.5371.1884.
8
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
J Virol. 1997 Oct;71(10):7478-87. doi: 10.1128/JVI.71.10.7478-7487.1997.
9
Chemokines.
Blood. 1997 Aug 1;90(3):909-28.
10
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Nature. 1996 Aug 29;382(6594):833-5. doi: 10.1038/382833a0.
Zotero 插件